ISC
  • #ISC25
  • Privacy Policy
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Resources
  • #ISC25
  • Privacy Policy
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon
Mar 16th, 2021

Understanding the potential of leptomeningeal collaterals in stroke

Exploring the unique mechanism of this collateral circulation in stroke.


Getty Images 1128680924

The leptomeningeal collaterals comprise a secondary blood flow route to avert, limit injury and aid reperfusion in ischemic stroke. These tiny arterial anastomoses (50-100 microns), spreading across the surface of the brain, can connect the territories of the main vessels, including the middle, anterior and posterior cerebral arteries.

The LMCs, also known as pial collaterals, are the heroes of moyamoya syndrome, a progressive stenosis of the intracranial internal carotid arteries and their proximal branches. In this condition, almost the entire blood flow to the brain is fed via the LMCs in this setting.

“The real question is, how do we achieve that therapeutically?” said David S. Liebeskind, MDDavid S. Liebeskind, MDDavid S. Liebeskind, MD, director of the UCLA Stroke Center. “Is there something we can do rather than see it occur in nature? Is there a way to trigger it to develop?”

That is the subject of Wednesday’s session, “The Leptomeningeal Collaterals: Understanding Their Specialized Function and Regulation in the Context of Stroke,” moderated by Liebeskind.

As collateral circuits go, the LMCs are anatomically and functionally different than other collateral circulation.

“The LMCs are interesting because except for a few other places in the body, they don’t exist anywhere else, and specifically they are very different than the collaterals that exist in the heart and to a large degree to the collaterals that exist in the peripheral arterial circulation as well,” said Liebeskind, who has studied the clinical relevance and impact of collateral circulation in acute ischemic stroke and intracranial atherosclerosis over the last 20 years.

The tiny anastomoses form selectively between the terminal limits or downstream branches of the arterial territory and the adjacent territory. “They allow the blood flow to go from one territory across a small connection and effectively backward into the other arterial territory,” said Liebeskind. “This retrograde or reverse arterial flow occurring in the downstream branches of a main arterial tree happens because there’s a blockage upstream in that vessel and the pressure drops. When it occurs in reverse fashion, the blood flow comes in through a few smaller vessels and then starts coursing toward the larger branches and trunks of that blocked arterial territory.”

The sudden increase in blood flow across small vessels causes an increase in shear stress, which effectively acts as a trigger to dilate the LMCs, consequently decreasing shear stress and increasing blood flow, he said.

“There are a lot of molecular mechanisms involved in terms of what gets triggered when this occurs, said Liebeskind. “In other words, it’s not just the physical forces, as you actually cause a leakiness of the LMCs at this level that allows them to dilate, to loosen their structure in the vessel wall and dilate outward.”

The session will focus on basic science research in LMCs. “The two principal avenues that have been attempted in animal models are either through increasing pressure at one end, or alternatively, attempting to dilate those blood vessels,” said Liebeskind.

Four science presentations will cover mechanisms of LMC dilation in response to stroke in young and aged mice, mechanisms of collateral failure in stroke, the modification of LMC function in hypertension and dysregulation of LMC function in models of Alzheimer's disease.

Much is yet to be learned about the tiny, yet mighty leptomeningeal collaterals and their role in stroke.

 

Interesting Stories
Stroke Risks and Prevention
Sponsored by American Heart Association/American Stroke Association
Stroke Risks and Prevention
NIH Stroke Scale
Sponsored by American Heart Association/American Stroke Association
NIH Stroke Scale
Connection Between Sleep and Cardiovascular Disease
Sponsored by American Heart Association/American Stroke Association
Connection Between Sleep and Cardiovascular Disease
Cholesterol for Professionals
Sponsored by American Heart Association/American Stroke Association
Cholesterol for Professionals
More Content
ISC21
State-of-the-Science Stroke Nursing Symposium
Register Now
Dec 6th, 2021
ISC21
AHA Professional Membership
Dec 6th, 2021
Getty Images 1170749170
ISC21
We want your feedback about #ISC22
Survey
Sep 20th, 2021
ISC21
Accessibility Statement
Sep 16th, 2021
Getty Images 1292736582
ISC21
Late-Breaking Science: New data in clot removal, stroke patients with COVID-19
Mar 19th, 2021
Getty Images 1178124559
ISC21
Debate: Optimal management for unruptured brain aneurysms
Mar 18th, 2021
Getty Images 1279891643
ISC21
Session highlights uncertainties in preventing stroke in COVID-19 patients
Mar 19th, 2021
Getty Images 1223133003
ISC21
Big data takes on stroke by the numbers
Mar 19th, 2021
Angels Partner Getty Images 1281414200
ISC21
ASA forms new partnership
Mar 19th, 2021
Academy Getty Images 1296726595
ISC21
Coming soon: AHA’s new health care education solution
Mar 19th, 2021
Maxresdefault 6054adb57d3ed
ISC21
Roos: MR CLEAN-NO IV results
Mar 19th, 2021
Maxresdefault 6054ab864857f
ISC21
Nogueira: SHRINE results
Mar 19th, 2021